Evidence map›Paper›PMID 42463788›Full record

ArticleCommunications medicine2026

Clinician expertise and prompt engineering enhance cancer information extraction in electronic health records by small language models.

Federica Corso, Vittoria Peppoloni, Laura Mazzeo, Giuseppe Leone, Luana Passos, Vanja Mišković, Justin Armanini, Alberto Ferrarin, Isabella Catharina Wiest, Fabian Wolf and 34 more

Abstract read
PubMed Publisher
In one paragraph

Article in Communications medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

44 authors.

Federica Corso *Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy. federica.corso@istitutotumori.mi.it.ORCID http://orcid.org/0000-0002-4947-9628
Vittoria Peppoloni *Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy.
Laura Mazzeo *Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy.
Giuseppe LeoneDepartment of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy.ORCID http://orcid.org/0009-0008-9931-9332
Luana PassosSchool of Medicine, University of Minho, Braga, Portugal.ORCID http://orcid.org/0009-0002-6577-7403
Vanja MiškovićDepartment of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy.ORCID http://orcid.org/0000-0003-1475-0243
Justin ArmaniniUniversity of Milano-Bicocca, Milan, Italy.ORCID http://orcid.org/0009-0003-3173-4971
Alberto FerrarinDepartment of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy.
Isabella Catharina WiestElse Kroener Fresenius Center for Digital Health, Faculty of Medicine and University Hospital Carl Gustav Carus, TUD Dresden University of Technology, Dresden, Germany.
Fabian WolfElse Kroener Fresenius Center for Digital Health, Faculty of Medicine and University Hospital Carl Gustav Carus, TUD Dresden University of Technology, Dresden, Germany.
Giulia MontelaticiDepartment of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy.ORCID http://orcid.org/0009-0001-7660-7998
Rebecca RomanòDepartment of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy.
Paolo AmbrosiniDepartment of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy.
Tommaso CapocciaDepartment of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy.
Stefano NatangeloDepartment of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy.ORCID http://orcid.org/0009-0002-3021-3085
Simone RotaDepartment of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy.
Paola AndenaDepartment of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy.
Marta De PontiDepartment of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy.
Alessandra RussoDepartment of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy.
Giulia StasiSchool of Medicine and Surgery, University of Milan, Milan, Italy.
Leonardo ProvenzanoDepartment of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy.
Andrea SpagnolettiDepartment of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy.
Marco Meazza PrinaDepartment of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy.
Chiara CavalliDepartment of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy.
Claudia GianiDepartment of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy.
Roberta SerinoDepartment of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy.
Michele BorracinoDepartment of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy.
Chiara BonalumeDepartment of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy.
Rosa Maria Di MauroDepartment of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy.
Claudia AgostaDepartment of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy.
Andra Diana DumitrascuDepartment of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy.
Giorgia Di LibertiDepartment of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy.ORCID http://orcid.org/0009-0000-1889-7520
Giulia CorraoDepartment of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy.ORCID http://orcid.org/0000-0002-5757-6073
Teresa BeninatoDepartment of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy.
Monica GanzinelliDepartment of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy.
Mario OcchipintiDepartment of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy.
Marta BrambillaDepartment of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy.
Claudia ProtoDepartment of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy.
Jakob Nikolas KatherElse Kroener Fresenius Center for Digital Health, Faculty of Medicine and University Hospital Carl Gustav Carus, TUD Dresden University of Technology, Dresden, Germany.ORCID http://orcid.org/0000-0002-3730-5348
Alessandra Laura Giulia PedrocchiDepartment of Electronic, Information and Bioengineering, Politecnico di Milano, Milan, Italy.
Filippo De BraudDepartment of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy.
Giuseppe Lo RussoDepartment of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy.
Paolo BailiDepartment of Epidemiology and Data Science, Data Science Unit, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy.
Arsela PrelajDepartment of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundReal-world data (RWD) in unstructured electronic health records (EHRs) is crucial for understanding complex diseases like cancer, but extracting structured information is challenging due to linguistic variability, semantic complexity, and privacy concerns. This study evaluates the performance of four small, locally deployable language models for information extraction from Italian EHRs.

methodsWe examine three prompting strategies (zero-shot, few-shot, and annotated few-shot) across English and Italian, involving clinicians with varying expertise to assess the impact of prompt design on accuracy. We evaluate the performance of four open-source small language models (SLMs) for clinical information extraction from Italian electronic health records (EHRs) in the APOLLO 11 trial on non-small cell lung cancer (NSCLC). The extraction protocol involves four steps: problem definition, data preprocessing, Large Language Model (LLM)-based information extraction, and output evaluation.

resultsWe show that general-purpose models (e.g., LLaMA 3.1 8B) outperform biomedical models in most tasks, particularly in extracting binary features. Multiclass variables such as TNM (Tumor, Node, Metastasis) staging, PD-L1 (Programmed death-ligand 1), and ECOG-PS (Eastern Cooperative Oncology Group-Performance Status) are more difficult due to implicit language and lack of standardization. Few-shot prompting and native-language inputs significantly improve performance and reduced hallucinations. Clinical expertise enhances consistency in the extraction, particularly among students using annotated examples.

conclusionsThe study confirms that privacy-preserving SLMs can be deployed locally for efficient and secure cancer data extraction. Findings highlight the need for hybrid systems combining SLMs with expert input and underline the importance of aligning clinical documentation practices with SLM capabilities. This is the first study to benchmark SLMs on Italian EHRs and investigate the role of clinical expertise in prompt engineering, offering valuable insights for the future integration of SLMs into real-world clinical workflows.

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.